Swedish probiotics player sales surge 16%

By Shane Starling

- Last updated on GMT

Related tags Lactobacillus Probiotic Lactobacillus reuteri

BioGaia has been investing in clinical research in 2010
BioGaia has been investing in clinical research in 2010
Swedish probiotics supplier and product manufacturer BioGaia has seen sales increase 16 per cent in 2010 to €27.77m from €23.08m in 2009, with after-tax profit increasing 31 per cent year-on-year to €5.35m.

Q4 after-tax profit jumped 90 per cent to €1.46m.

“On the whole, we thus had a very strong development during 2010 and are building value by investing further in clinical research, product development and the BioGaia brand,"​ said BioGaia president Peter Rothschild.

The company highlight research advances in Q4. These included the publication of a study demonstrating Lactobacillus reuteri Protectis​ is effective in treatment of periodontitis, a common, chronic inflammatory disease that is characterised by gum tissue separation from the tooth – forming a periodontal pocket that can lead to bone and tooth loss.

Another study found Lactobacillus reuteri Protectis​ reduced regurgitation and improved stomach emptying in infants.


The company also signed two significant agreements in Q4, one in Greece for its Oral Rehydration Solution.

Its 50 per cent-owned company, TwoPac, which manufactures advanced ingredient delivery systems also established a new facility in Eslöv, Sweden.

Correction: This article has been amended to remove inadvertent references to another Swedish probiotics supplier.

Related news

Show more

Related products

show more

Innovation in convenient formats: vegan gummies

Innovation in convenient formats: vegan gummies

Content provided by Cambridge Commodities | 05-Mar-2024 | Product Brochure

Supplements and vitamins in pill form have been around for decades, but consumers are now seeking alternatives that fit with their busy lifestyles and...

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Related suppliers

1 comment


Posted by Jason Ryz,

Probi is an excellent company that I am glad is doing well in such a competitive market. Probi should consider merging with a US-based company because the market is rapidly increasing.

Report abuse

Follow us


View more